Parecoxib FDA Approval Status
Parecoxib sodium is a non-narcotic injectable COX-2 selective analgesic for the treatment of acute pain.
In September 2005, Pfizer Inc. announced the receipt of a Complete Response Letter from the U.S. Food and Drug Administration (FDA), advising the company that the New Drug Application (NDA) for parecoxib had not been approved.
Development Timeline for Parecoxib
|Sep 20, 2005||Pfizer Receives FDA Non-Approvable Letter on Parecoxib|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.